Search research articles
Contact Us
Filters
Showing results (81-90 of 148) with videos related to
Page
of 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 30, 2019
Patterns of recurrence after prostate bed radiotherapy
Douglas H Brand, Joanna I Parker, David P Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 7, 2021
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
The Lancet. Oncology
|
January 2, 2013
Stereotactic body radiotherapy for oligometastases
Alison C Tree, Vincent S Khoo, Rosalind A Eeles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 24, 2004
Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement
Elizabeth J Adams, David J Convery, Vivian P Cosgrove, et al.
Journal of the National Cancer Institute
|
May 17, 2007
Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873)
Malcolm D Mason, Matthew R Sydes, John Glaholm, et al.
Journal of the National Cancer Institute
|
September 4, 2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)
David P Dearnaley, Matthew R Sydes, Malcolm D Mason, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)
David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 22, 2007
A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer
Teresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2017
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
Miguel Reis Ferreira, Atia Khan, Karen Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 2, 2007
Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study
Teresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 148) with videos related to
Sort By:
Page
of 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 30, 2019
Patterns of recurrence after prostate bed radiotherapy
Douglas H Brand, Joanna I Parker, David P Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 7, 2021
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
The Lancet. Oncology
|
January 2, 2013
Stereotactic body radiotherapy for oligometastases
Alison C Tree, Vincent S Khoo, Rosalind A Eeles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 24, 2004
Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement
Elizabeth J Adams, David J Convery, Vivian P Cosgrove, et al.
Journal of the National Cancer Institute
|
May 17, 2007
Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873)
Malcolm D Mason, Matthew R Sydes, John Glaholm, et al.
Journal of the National Cancer Institute
|
September 4, 2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)
David P Dearnaley, Matthew R Sydes, Malcolm D Mason, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)
David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 22, 2007
A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer
Teresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2017
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
Miguel Reis Ferreira, Atia Khan, Karen Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 2, 2007
Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study
Teresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.
Page
of 15